MATW — Matthews International Corporation · 2026-09-06 · Verdict: WATCH · Conviction 3
Price $21.13 (screen row in universe_under2b.csv, built 2026-09-06; no live quote available) · Mkt cap $659.5M (31.21M shares) · EV ~$1.19B · EV/EBIT 15.7x on CY2025 GAAP EBIT of $75.5M (~7.4x FY26 guided adjusted EBITDA of $158-162M, ~10.3x excluding the Propelis share) · FCF yield negative (nine-month FY26 operating cash flow -$69.5M) · Net debt $529.7M · ADV $17.9M · 26% below the 52-week high Sources read: 10-K 2025-11-21 (Items 1, 1A, 7), 10-Q 2026-08-07 (Item 2), DEF 14A 2026-01-20, 8-Ks 2026-04-30, 2026-05-01, 2026-07-30, 2026-08-04, 2026-08-07, 2026-08-11, 2026-09-04, Form 4s (trailing 12m). No conference call transcript or prepared remarks were filed as an exhibit; the bundle's "transcript" file is the Q3 FY26 press release (EX-99.1, 2026-08-07).
1. What the business actually does
Matthews, founded 1850, now runs two consolidated businesses plus one stake. Memorialization makes bronze and granite memorials, caskets, embalming chemicals, urns and cremation/incineration equipment for cemeteries, funeral homes and crematories, mostly in North America. Industrial Technologies makes product identification and inkjet marking systems plus purpose-built engineered equipment: calendering and coating lines for dry-electrode lithium-ion battery manufacturing, and coating and converting lines for packaging and pharma (10-K 2025, Item 1). Brand Solutions is now nothing but a 40% interest in Propelis, the roughly $1 billion revenue brand-services venture formed May 1, 2025 when Matthews contributed SGK and it merged with SGS & Co. Warehouse automation and the European roto-gravure packaging, tooling and flexographic print businesses were sold in December 2025 (10-Q Q3 2026, Item 2).
2. Why it is mispriced — the edge case
The honest edge is accounting legibility, not neglect: at $17.9M of average daily volume this is not an ignored microcap. Consolidated sales fell 33% in nine-month FY26, to $789.4M from $1,178.8M, essentially all divestiture (10-Q Q3 2026, Item 2). The segment perimeter has been redrawn three times in eighteen months, Propelis is equity-method on a one-quarter lag, and headline adjusted EBITDA now blends consolidated cash EBITDA with a 40% non-cash share of a joint venture. Our own screen was defeated by this: EV/EBIT of 15.7x off CY2025 EBIT, flagged on momentum rather than cheapness. Underneath, Memorialization earned $164.0M, $162.6M and $169.5M of adjusted EBITDA in fiscal 2023, 2024 and 2025 on almost flat sales (10-K 2025, Item 7). One stable segment is most of a $1.19B enterprise value.
The same opacity cuts the other way, which is why this is a WATCH and not an IDEA. The FY26 guide of $158-162M "includes our estimated 40% share of Propelis adjusted EBITDA" (8-K 2026-08-07, EX-99.1). Propelis supplied $32.4M of that in nine months, but Matthews' 40% share of Propelis depreciation, amortization and interest was $49.6M over the same period and the equity-method line was a $17.2M loss (10-Q Q3 2026, Item 2). The lenders reached the same conclusion: the Ninth Amendment signed September 1, 2026 excludes the Propelis interest from the leverage ratio entirely, grants a Covenant Relief Period through December 31, 2027 at a maximum 5.25x, and cuts revolver capacity from $700M to $650M (8-K 2026-09-04). Strip Propelis and roughly $115M of EBITDA supports $529.7M of net debt.
3. Unit economics and growth
Memorialization is the asset. Margins crept from 19.5% in fiscal 2023 to 20.9% in fiscal 2025, and 20.7% for nine-month FY26 (10-K 2025, Item 7; 8-K 2026-08-07, EX-99.1). But the third quarter shows the squeeze: sales $208.1M against $203.7M, adjusted EBITDA $42.2M against $42.8M, margin 20.3% versus 21.0%. Growth is entirely the Dodge acquisition; unit volumes of caskets and cemetery memorials fell on "lower estimated U.S. casketed deaths," and "inflationary price realization only partially offset" escalating input costs including unrefunded tariffs (8-K 2026-08-07, EX-99.1).
Industrial Technologies has collapsed: adjusted EBITDA of $66.3M in FY23, $39.7M in FY24, $27.9M in FY25, and a loss of $13.2M in nine-month FY26 on $150.3M of sales (10-K 2025, Item 7; 10-Q Q3 2026, Item 2). Product Identification grew 5% in the quarter; engineering is the hole, and a Q3 European restructuring buys $10M of annual savings at $10M cost to achieve (8-K 2026-08-07, EX-99.1).
The company says no single customer is individually significant, yet $98.1M of net contract assets at June 30, 2026 "predominantly related to ongoing projects with Tesla," a customer suing Matthews for trade secret misappropriation since June 2024 with a second inventorship complaint filed February 13, 2025 (10-Q Q3 2026, Item 2; 10-K 2025, Item 1A). Tesla legal costs were $18.9M in nine-month FY26 and $22.2M in FY25. That is concentration by any practical definition.
Cash conversion is the problem, not the multiple. Operating cash flow was negative $23.6M in FY25 and negative $69.5M in nine-month FY26 (10-K 2025, Item 7; 8-K 2026-08-07, EX-99.1). Excluding $109.5M of divestiture gains, nine-month GAAP operating profit was a $28.4M loss.
4. Balance sheet and capital allocation
Net debt fell from $678.4M at September 30, 2025 to $529.7M at June 30, 2026, funded by $243.6M of divestiture proceeds plus $28M of Propelis preferred redemptions, not by operations (8-K 2026-08-07, EX-99.1). The 8.625% 2027 notes were redeemed in January 2026 at 104.313% for $320.9M, costing a $16.3M extinguishment charge; the replacement is a $404.6M revolver draw plus a $134.9M amortizing term loan at SOFR plus 1.75%, weighted average 5.37% versus 3.99% a year earlier, maturing January 31, 2029 (10-Q Q3 2026, Item 2). Meanwhile the dividend was raised 2% to $0.255 quarterly, $25.6M of cash out over nine months, alongside $5.8M of buybacks, against negative operating cash flow. Three directors bought 13,000 shares for $298,122 in August 2026 with zero sales, the largest by David Schawk at $23.60 on August 10 (Form 4s, 2026-08-10 to 2026-08-25). Small, but directionally right and after the guidance cut.
5. Management: said versus did
The FY25 10-K stated "The Company expects to generate sufficient cash from operations to fund all anticipated capital spending projects" (Item 7). Operating cash flow has been negative in both periods since, and FY26 capex guidance was cut from $30-40M in that 10-K to $15-25M by the Q3 10-Q. The strategic alternatives review announced November 2024 is, twenty-two months later, still "ongoing" (10-Q Q3 2026, Item 2). On August 6, 2026 the CEO cut guidance to $158-162M citing energy storage delays, Memorialization input costs and a $5M Propelis synergy shortfall (8-K 2026-08-07). Two days earlier Joseph Bartolacci announced his retirement after 20 years as CEO; Michael Whitehead, from Lincoln Electric, took over August 31, 2026 on a $1.0M salary with a $3.675M FY27 equity target and a $1.6M one-time RSU grant (8-K 2026-08-04; 8-K 2026-08-11).
6. Valuation
Base (50%): Memorialization $170M EBITDA at 8x, corporate overhead of $35M capitalized at the same multiple, Industrial Technologies at zero, Propelis marked at half its $246.5M carrying value. EV ~$1,203M less $529.7M net debt gives about $21.6 per share. Bull (25%): Memorialization $175M at 9x, corporate cut to $25M as post-divestiture support obligations expire, Industrial Technologies partnered or sold for $150M, Propelis at full carrying value, roughly $39 per share. Bear (25%): death rates and tariffs push Memorialization to $155M at 6.5x, corporate stays $40M, Industrial Technologies costs $50M to exit, Propelis to zero, roughly $5 per share. Probability weighted: about $22 against $21.13.
Reverse DCF: at $21.13 with $529.7M of net debt, the enterprise value of roughly $1.19B implies about $119M of perpetual unlevered free cash flow at a 10% discount rate with no growth, versus FY26 guided adjusted EBITDA of $158-162M that contains roughly $45M of non-cash Propelis equity-method contribution and against two consecutive periods of negative operating cash flow. The price is not asking for growth. It is asking management to convert segment EBITDA into cash, which it has not done since fiscal 2024.
7. Catalysts and timeline
FY26 results and the 10-K in November 2026, the first cash-flow print not distorted by divestiture proceeds. Whitehead's first strategy communication, likely by the March 2027 annual meeting. An Industrial Technologies partnership or sale from the ongoing strategic review. Further Propelis preferred redemptions converting the stake to cash. Resolution of the Tesla litigation, which frees the $98.1M contract-asset balance in either direction.
8. Risks and pre-registered kill criteria
- Memorialization adjusted EBITDA margin below 19.0% for two consecutive quarters (20.3% in Q3 FY26, 20.7% year to date).
- Fiscal 2026 full-year operating cash flow still negative when the 10-K is filed, or fiscal 2027 first-half operating cash flow negative again.
- Reported leverage ratio above 5.00x at any quarter end during the Covenant Relief Period, or any further amendment or waiver required under the credit agreement.
- An adverse Tesla ruling or settlement that impairs the $98.1M of net contract assets, or Industrial Technologies adjusted EBITDA still negative at the fiscal 2027 half-year.
Also outside the kill list: U.S. casketed death rates fall structurally as cremation share rises, and Chinese casket imports compete on price (10-K 2025, Item 1A); Propelis is levered and outside the collateral package; the new CEO has no memorialization background.
9. Verdict and summary
WATCH, conviction 3. Matthews is a stable $170M-EBITDA memorialization business carrying a loss-making industrial equipment arm, $530M of net debt and a 40% stake in a levered brand-services joint venture, and at $21.13 the market already pays roughly 8x for the good segment and assigns the rest close to nothing. The sum-of-parts is genuinely obscured, by three segment redefinitions in eighteen months and an adjusted EBITDA figure that mixes cash earnings with a non-cash JV share, and three directors bought stock in August after the guidance cut. But the thing that would make it cheap has not happened: operating cash flow was negative $23.6M in fiscal 2025 and negative $69.5M in nine-month fiscal 2026, debt reduction was funded entirely by asset sales, the dividend was raised anyway, and on September 1, 2026 the lenders granted covenant relief to 5.25x while explicitly excluding Propelis from the leverage test. A new CEO arrived August 31 and the strategic review is twenty-two months old with no outcome for Industrial Technologies. Wait for one clean quarter of positive operating cash flow, or a signed Industrial Technologies transaction, before paying up.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.